June 20, 2024
1 min read

India’s Pharma Exports Boom

India is now the world’s third-largest drugmaker by volume amid the growing demand for the country’s pharmaceutical products in export markets….reports Asian Lite News

India’s pharmaceutical exports continue to register double-digit growth, reflecting the strong demand for the country’s affordable generic medicines in global markets led by the USA and UK.

India’s pharma exports grew by 10.45 per cent in May this year to touch the $2.3 billion mark compared with the $2.08 billion in the same month of the previous financial year.

“It is moving in a positive way and we are optimistic of sustaining growth of not less than 10 per cent,” Director General, Pharmaceuticals Export Promotion Council of India, Ravi Uday Bhaskar said on the quick estimate numbers released last week by the Centre.

India is now the world’s third-largest drugmaker by volume amid the growing demand for the country’s pharmaceutical products in export markets.

The US is a key market, which accounts for about 30 per cent of India’s annual pharma exports after a nearly 16 per cent increase in fiscal 2024, according to Pharmexcil.

The country’s drug shortages as well as the increased use of drugs for lifestyle diseases such as diabetes, hypertension and depression is expected to fuel the demand for India’s affordably priced drugs, according to Bhaskar.

According to a report by India Ratings and Research, Indian drugmakers will sustain their revenue improvement in 2024-2025 due to drug shortages in the United States. India is a hub of bulk generic drug manufacturing and drugmakers including Dr Reddy’s, Cipla, Sun Pharma derive a significant share of revenue from both the US and Europe.

The world’s largest drug market is facing decade-high drug shortages, India Ratings said in a note citing data from with Utah Drug Information Service.

There is an active shortage of 233 drugs across 22 therapeutic categories as of April, led mainly by discontinuing production of some drugs, rising demand and delays in shipments, it said, also citing data from the US Food and Drug Administration.

ALSO READ: India’s ‘Electric’ Awakening

Previous Story

Connected Health to Drive 22% of Life Sciences Revenue

Next Story

Cong urges PM to take responsibility for stopping paper leak

Latest from Business

Nvidia slams US chip export curbs as ‘failure’

Jensen Huang said the US move has backfired by accelerating China’s self-sufficiency in semiconductors and diminishing American dominance in the global chip market…reports Asian Lite News Nvidia CEO Jensen Huang has sharply

SEBI Warns on Strata Exit

Strata was one of the first platforms to register under SEBI’s newly introduced SM REIT framework, which was designed to regulate fractional ownership in real estate and allow investors to pool capital
Go toTop

Don't Miss

Manmohan Singh conferred Lifetime Achievement Honour  

British Indian peer Lord Karan Bilimoria received the Living Legend

Kashmiri activist calls out persecution in Pakistan at Geneva event

The activist detailed the range of human rights violations faced